224 related articles for article (PubMed ID: 11920533)
1. Transcervical needle biopsy for the differential diagnosis between uterine sarcoma and leiomyoma.
Kawamura N; Ichimura T; Ito F; Shibata S; Takahashi K; Tsujimura A; Ishiko O; Haba T; Wakasa K; Ogita S
Cancer; 2002 Mar; 94(6):1713-20. PubMed ID: 11920533
[TBL] [Abstract][Full Text] [Related]
2. Telomerase activity in needle biopsied uterine myoma-like tumors: differential diagnosis between uterine sarcomas and leiomyomas.
Tsujimura A; Kawamura N; Ichimura T; Honda K; Ishiko O; Ogita S
Int J Oncol; 2002 Feb; 20(2):361-5. PubMed ID: 11788902
[TBL] [Abstract][Full Text] [Related]
3. Preoperative ultrasound-guided needle biopsy of 63 uterine tumors having high signal intensity upon T2-weighted magnetic resonance imaging.
Tamura R; Kashima K; Asatani M; Nishino K; Nishikawa N; Sekine M; Serikawa T; Enomoto T
Int J Gynecol Cancer; 2014 Jul; 24(6):1042-7. PubMed ID: 24927248
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the predictivity of preoperative serum CA 125 in the differential diagnosis of uterine leiomyoma and uterine sarcoma in the Turkish female population.
Yilmaz N; Sahin I; Kilic S; Ozgu E; Gungor T; Bilge U
Eur J Gynaecol Oncol; 2009; 30(4):412-4. PubMed ID: 19761133
[TBL] [Abstract][Full Text] [Related]
5. Sarcomas and the conservative management of uterine fibroids: a cause for concern?
Dover RW; Ferrier AJ; Torode HW
Aust N Z J Obstet Gynaecol; 2000 Aug; 40(3):308-12. PubMed ID: 11065039
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil to lymphocyte ratio for preoperative diagnosis of uterine sarcomas: a case-matched comparison.
Kim HS; Han KH; Chung HH; Kim JW; Park NH; Song YS; Kang SB
Eur J Surg Oncol; 2010 Jul; 36(7):691-8. PubMed ID: 20570475
[TBL] [Abstract][Full Text] [Related]
7. A scoring system for histopathologic and immunohistochemical evaluations of uterine leiomyosarcomas.
Yoshida C; Ichimura T; Kawamura N; Nakano A; Kasai M; Sumi T; Ishiko O
Oncol Rep; 2009 Oct; 22(4):725-31. PubMed ID: 19724849
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of PET/CT to exclude leiomyoma in patients with lesions suspicious for uterine sarcoma on MRI.
Kusunoki S; Terao Y; Ujihira T; Fujino K; Kaneda H; Kimura M; Ota T; Takeda S
Taiwan J Obstet Gynecol; 2017 Aug; 56(4):508-513. PubMed ID: 28805609
[TBL] [Abstract][Full Text] [Related]
9. Fertility-sparing approach in a teenager with uterine tumor diagnosed as a sarcoma on imaging.
Berveiller P; Mir O; Menu Y; Jamali M; Carbonne B
Gynecol Obstet Invest; 2010; 69(3):157-9. PubMed ID: 20016187
[TBL] [Abstract][Full Text] [Related]
10. Correlation between shrinkage of uterine leiomyoma treated with buserelin acetate and histopathologic findings of biopsy specimen before treatment.
Kawamura N; Ito F; Ichimura T; Shibata S; Umesaki N; Ogita S
Fertil Steril; 1997 Oct; 68(4):632-6. PubMed ID: 9341601
[TBL] [Abstract][Full Text] [Related]
11. Utility of Clinical Parameters and Multiparametric MRI as Predictive Factors for Differentiating Uterine Sarcoma From Atypical Leiomyoma.
Bi Q; Xiao Z; Lv F; Liu Y; Zou C; Shen Y
Acad Radiol; 2018 Aug; 25(8):993-1002. PubMed ID: 29422425
[TBL] [Abstract][Full Text] [Related]
12. [Malignancy of uterine sarcoma in comparison with suspect leiomyoma. An anatomo-clinical study of 16 cases].
Socolov RV; Pricop FZ; Stratan D
Rev Fr Gynecol Obstet; 1992 Oct; 87(10):457-60. PubMed ID: 1470817
[TBL] [Abstract][Full Text] [Related]
13. Preliminary utilization of radiomics in differentiating uterine sarcoma from atypical leiomyoma: Comparison on diagnostic efficacy of MRI features and radiomic features.
Xie H; Hu J; Zhang X; Ma S; Liu Y; Wang X
Eur J Radiol; 2019 Jun; 115():39-45. PubMed ID: 31084757
[TBL] [Abstract][Full Text] [Related]
14. Specificity of the lactate dehydrogenase isoenzyme index as a preoperative screen for uterine sarcoma before myomectomy.
Spivack LE; Glantz JC; Lennon C; Bhagavath B
Fertil Steril; 2021 Jan; 115(1):174-179. PubMed ID: 33070962
[TBL] [Abstract][Full Text] [Related]
15. Transient shrinkage of a uterine leiomyosarcoma treated with GnRH agonist for a presumed uterine leiomyoma: comparison of magnetic resonance imaging finding before and during GnRH agonist treatment.
Kawamura N; Iwanaga N; Hada S; Maeda K; Sumi T; Ishiko O; Ogita S
Oncol Rep; 2001; 8(6):1255-7. PubMed ID: 11605044
[TBL] [Abstract][Full Text] [Related]
16. Differential diagnosis between uterine sarcoma and leiomyoma using preoperative clinical characteristics.
Cho HY; Kim K; Kim YB; No JH
J Obstet Gynaecol Res; 2016 Mar; 42(3):313-8. PubMed ID: 26695124
[TBL] [Abstract][Full Text] [Related]
17. Preliminary observations and clinical value of lipid peak in high-grade uterine sarcomas using in vivo proton MR spectroscopy.
Takeuchi M; Matsuzaki K; Harada M
Eur Radiol; 2013 Sep; 23(9):2358-63. PubMed ID: 23740024
[TBL] [Abstract][Full Text] [Related]
18. Fertility-sparing management of a suspicion of leiomyosarcoma: avoiding hysterectomy by performing transcervical myoma biopsy.
Duraes M; Mandoul C; Perrochia H; Rathat G
Fertil Steril; 2022 Jan; 117(1):230-231. PubMed ID: 34753598
[TBL] [Abstract][Full Text] [Related]
19. Age-stratified risk of unexpected uterine sarcoma following surgery for presumed benign leiomyoma.
Brohl AS; Li L; Andikyan V; Običan SG; Cioffi A; Hao K; Dudley JT; Ascher-Walsh C; Kasarskis A; Maki RG
Oncologist; 2015 Apr; 20(4):433-9. PubMed ID: 25765878
[TBL] [Abstract][Full Text] [Related]
20. [Cytomorphological diagnosis of nonepithelial tumors of the uterus].
Novik VI
Arkh Patol; 1985; 47(8):45-52. PubMed ID: 3000322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
